Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Hanmi Out-licenses pan-RAF Inhibitor to Genentech for $920 Million (in: Deals & Financings)
  Fosun Forms $100 Million China Medical Device JV with Intuitive Surgical (in: Deals & Financings)
  Zai Lab Acquires China Rights to TESARO's PARP Inhibitor (in: Deals & Financings)
  ReedCoor Raises $23 Million from China Investors for Novel NGS Technology (in: Deals & Financings)
  Huanzhong Biotech to Market Concepta's Fertility Product in China (in: Deals & Financings)
  Huapont In-Licenses China Rights to Histogen's Stem Cell Hair Growth Injections (in: Deals & Financings)
  China BioPharma Capital Invests in Quantapore, a Sequencing Device Maker (in: Deals & Financings)
  China's CANbridge Starts Taiwan Trial of Novel Brain Cancer Drug (in: Trials & Approvals)
  Neusoft and Infinity Announce a $250 Million China-Israel Investment Fund (in: Deals & Financings)
  MicuRx Raises $55 Million for China-US Development of Novel Antibiotic (in: Deals & Financings)


ChinaBio® Events